Search research articles
Contact Us
Filters
Showing results (61-70 of 210) with videos related to
Page
of 21
Sort By:
Research Publications - Association for Research in Nervous and Mental Disease
|
January 1, 1990
Noninflammatory immune mechanisms in diseases of the nervous system
D P Richman, R H Fairclough, Q Xu, et al.
Annals of the New York Academy of Sciences
|
June 21, 1993
Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin binding
Q Xu, G M Twaddle, D P Richman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1994
Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity
M Mihovilovic, D Donnelly-Roberts, D P Richman, et al.
Annals of the New York Academy of Sciences
|
July 21, 1998
Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis
C A Kirvan, S Zhu, D P Richman, et al.
Annals of the New York Academy of Sciences
|
January 1, 1987
Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis
K Stefansson, M E Dieperink, D P Richman, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies
R A Maselli, B Jow, D P Richman, et al.
Pediatric Hematology and Oncology
|
July 1, 1993
Polycythemia: a review article and case report of erythrocytosis secondary to Wilms' tumor
A K Souid, A S Dubansky, P Richman, et al.
Experimental Neurology
|
January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug development
Anna Rostedt Punga, Henry J Kaminski, David P Richman, et al.
European Journal of Immunology
|
February 3, 2015
Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice
Sheena R Baratono, Niansheng Chu, Lee P Richman, et al.
American Journal of Clinical Pathology
|
May 25, 2025
Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia varies with interpreter expertise and mutation status
Lee P Richman, Brianna F Waller, Scott B Lovitch, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 210) with videos related to
Sort By:
Page
of 21
Research Publications - Association for Research in Nervous and Mental Disease
|
January 1, 1990
Noninflammatory immune mechanisms in diseases of the nervous system
D P Richman, R H Fairclough, Q Xu, et al.
Annals of the New York Academy of Sciences
|
June 21, 1993
Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin binding
Q Xu, G M Twaddle, D P Richman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1994
Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity
M Mihovilovic, D Donnelly-Roberts, D P Richman, et al.
Annals of the New York Academy of Sciences
|
July 21, 1998
Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis
C A Kirvan, S Zhu, D P Richman, et al.
Annals of the New York Academy of Sciences
|
January 1, 1987
Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis
K Stefansson, M E Dieperink, D P Richman, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies
R A Maselli, B Jow, D P Richman, et al.
Pediatric Hematology and Oncology
|
July 1, 1993
Polycythemia: a review article and case report of erythrocytosis secondary to Wilms' tumor
A K Souid, A S Dubansky, P Richman, et al.
Experimental Neurology
|
January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug development
Anna Rostedt Punga, Henry J Kaminski, David P Richman, et al.
European Journal of Immunology
|
February 3, 2015
Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice
Sheena R Baratono, Niansheng Chu, Lee P Richman, et al.
American Journal of Clinical Pathology
|
May 25, 2025
Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia varies with interpreter expertise and mutation status
Lee P Richman, Brianna F Waller, Scott B Lovitch, et al.
Page
of 21